John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$267M |
| 2 |
Amazon
AMZN
|
+$243M |
| 3 |
Applied Materials
AMAT
|
+$242M |
| 4 |
Airbnb
ABNB
|
+$221M |
| 5 |
Meta Platforms (Facebook)
META
|
+$213M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$262M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$259M |
| 3 |
Wells Fargo
WFC
|
+$238M |
| 4 |
Broadcom
AVGO
|
+$233M |
| 5 |
Applovin
APP
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.95% |
| 2 | Healthcare | 13.56% |
| 3 | Financials | 11.46% |
| 4 | Consumer Discretionary | 9.22% |
| 5 | Industrials | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCG
2926
Binah Capital Group
BCG
$24.9M
| $79K | ﹤0.01% |
+26,871
| New | +$70.1K |
|
|
ATYR
2927
aTyr Pharma
ATYR
$52M
| $78.3K | ﹤0.01% |
+21,628
| New | +$65.5K |
|
2928
Smart Sand
SND
$198M
| $77.7K | ﹤0.01% |
34,521
-141
| -0.4% | -$315 |
|
2929
reAlpha
AIRE
$9.41M
| $77.1K | ﹤0.01% |
+1,067
| New | +$33.2K |
|
2930
Identive
INVE
$69.3M
| $76.7K | ﹤0.01% |
20,944
-4,328
| -17% | -$16.2K |
|
|
SOWG
2931
Sow Good
SOWG
$62.4M
| $76.1K | ﹤0.01% |
+2,488
| New | +$247K |
|
2932
Harvard Bioscience
HBIO
$34.4M
| $75.6K | ﹤0.01% |
3,582
+211
| +6% | +$4.85K |
|
2933
Air Industries Group
AIRI
$11.3M
| $74.3K | ﹤0.01% |
+18,260
| New | +$93.8K |
|
2934
Rallybio
RLYB
$89.2M
| $73.7K | ﹤0.01% |
9,601
-1,190
| -11% | -$9.97K |
|
|
MRIN
2935
DELISTED
Marin Software
MRIN
| $73K | ﹤0.01% |
33,023
-6,195
| -16% | -$13.1K |
|
|
FIRY
2936
Firy Inc
FIRY
$151M
| $72.8K | ﹤0.01% |
14,480
-1,584
| -10% | -$8.45K |
|
2937
ImmunityBio
IBRX
$8.03B
| $72.5K | ﹤0.01% |
+28,317
| New | +$118K |
|
|
AGIG
2938
Abundia Global Impact Group
AGIG
$43.3M
| $72K | ﹤0.01% |
5,582
-1,116
| -17% | -$15.2K |
|
2939
Protara Therapeutics
TARA
$229M
| $72K | ﹤0.01% |
13,633
-171,590
| -93% | -$554K |
|
2940
KULR Technology Group
KULR
$119M
| $71.7K | ﹤0.01% |
2,525
+1,031
| +69% | +$8.04K |
|
|
ACHL
2941
DELISTED
Achilles Therapeutics
ACHL
| $70.3K | ﹤0.01% |
61,637
+40,388
| +190% | +$41.6K |
|
2942
BigBear.ai
BBAI
$1.47B
| $70.1K | ﹤0.01% |
+15,753
| New | +$35.6K |
|
2943
Sight Sciences
SGHT
$462M
| $69K | ﹤0.01% |
18,944
+3,151
| +20% | +$14.3K |
|
|
GOEV
2944
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $68.8K | ﹤0.01% |
+48,790
| New | +$531K |
|
2945
Cibus
CBUS
$132M
| $68.3K | ﹤0.01% |
+24,574
| New | +$95.2K |
|
2946
Century Therapeutics
IPSC
$384M
| $67.5K | ﹤0.01% |
+66,797
| New | +$90.9K |
|
2947
Enel Chile
ENIC
$6.27B
| $67.5K | ﹤0.01% |
23,425
-6,575
| -22% | -$18.3K |
|
2948
Relmada Therapeutics
RLMD
$489M
| $66.3K | ﹤0.01% |
127,579
-63,736
| -33% | -$155K |
|
2949
Tonix Pharmaceuticals
TNXP
$214M
| $66.2K | ﹤0.01% |
+2,008
| New | +$41.7K |
|
|
CMBM
2950
DELISTED
Cambium Networks
CMBM
| $65.4K | ﹤0.01% |
101,484
-569
| -0.6% | -$670 |
|
Similar funds
John Overdeck's Q4 2024 Portfolio in Review
As of Q4 2024, John Overdeck held 3,590 positions worth $45.9B, up 0.48% from $45.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $1.69B in Q4 2024, closing 427 positions and reducing 1,388 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $184M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
Against the trend, John Overdeck opened a new position in Intel worth $237M.
- John Overdeck's largest Q4 2024 buy was Intel: 11,843,258 shares worth $237M.
- John Overdeck added most to Amazon in Q4 2024, an estimated $243M increase.
- John Overdeck's biggest Q4 2024 reduction was Micron Technology, cutting an estimated $262M.
- John Overdeck fully exited iShares MSCI Emerging Markets ETF in Q4 2024, selling an estimated $184M.
- John Overdeck's ten largest holdings make up 7.2% of its $45.9B portfolio in Q4 2024.
- John Overdeck opened 477 new positions and closed 427 in Q4 2024.
- John Overdeck's portfolio value rose 0.48% quarter-over-quarter to $45.9B.
Based on Two Sigma Investments's 13F filing for Q4 2024, filed 14 Feb 2025.